Navigation Links
Pradaxa Lawsuits Progress, as Bernstein Liebhard LLP Notes Establishment of Bellwether Case Selection Protocol in Federal Pradaxa Bleeding Litigation

New York, New York (PRWEB) November 11, 2013

Pradaxa lawsuits ( filed on behalf of individuals who suffered serious instances of internal bleeding, allegedly due to Pradaxa, continue to move forward in a multidistrict litigation underway in U.S. District Court, Southern District of Illinois, Bernstein Liebhard LLP reports. According to a Case Management Order issued on November 4th, the Court has established a protocol for the selection of bellwether cases in the Pradaxa bleeding litigation. Among other things, the Order directs the parties to each select up to three individual Pradaxa lawsuits as possible bellwether cases, and submit their selections to the Court on December 15th at 5:00 p.m. By January 23, 2014, the Court will select four of those cases for the litigation’s first bellwether trials. Those trials are scheduled to begin in August 2014. (In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation – MDL No. 2385)

“The selection of bellwether trials will mark an important milestone in the Pradaxa bleeding litigation. We are pleased to see this proceeding moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free legal evaluations to alleged victims of Pradaxa bleeding side effects.

Pradaxa Lawsuits
According to court documents, at least 1,767 Pradaxa lawsuits are now pending in the litigation underway in the Southern District of Illinois. Plaintiffs allege that Boehringer Ingelheim failed to provide adequate warnings to doctors and patients regarding the lack of a readily available antidote to reverse Pradaxa bleeding.

In October, the Institute for Safe Medicine Practices (ISMP) reported that the U.S. Food & Drug Administration (FDA) had tallied more than 3,292 reports of adverse events and 582 deaths involving Pradaxa side effects in 2012, more than any other drug it tracked that year.* According to a recent report, regulators in several countries have issued Pradaxa side effect alerts, mostly due to its association with internal bleeding. Though the drug has been marketed as an improvement over warfarin, internal hemorrhaging caused by that decades-old blood thinner can be ended via the administration of vitamin K. However, there as yet exists no readily available antidote to reverse bleeding that can sometimes accompany Pradaxa use.**

Individuals allegedly injured by Pradaxa may be entitled to compensation for medical expenses, lost wages, pain and suffering, and more. Learn More about possible Pradaxa side effects by visiting Bernstein Liebhard LLP’s website. For a free review of your potential Pradaxa lawsuit, please call 800-511-5092.

*, ISMP, October 17, 201
**,, December 11, 2012

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Pradaxa Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Issuance of New Order in Federal Pradaxa Bleeding Litigation
2. New Data on Pradaxa Bleeding Side Effects Draws Comment from Pradaxa Lawsuit Lawyers at Wright & Schulte LLC
3. DrugRisk Alert: Pradaxa Leads Study of Complication Reports to FDA
4. DrugNews: Court Records Show Growth In Claims Alleging Pradaxa Bleeding Injury
5. Doyle Raizner Attorney Presenting Pradaxa MDL Update at AAJ Seminar
6. DrugNews: Pradaxa Study Reveals Stroke, Bleeding and Heart Attack Risks In Some Patients
7. Pradaxa Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Pradaxa Bleeding Litigation
8. Pradaxa Bleeding Lawsuits Help: Resource4thePeople Reports another Medical Research Study Finds Increased Bleeding Risks
9. Pradaxa Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Issuance of New Case Management Order in Federal Pradaxa Bleeding Litigation
10. Pradaxa Lawsuit News: Bernstein Liebhard LLP Comments on Study Findings Regarding Use of Pradaxa in Mechanical Heart Valve Patients
11. Pradaxa Bleeding Lawyers at Wright & Schulte LLC Note Growing Number of Filings in Federal Multidistrict Litigation Established for Pradaxa Lawsuits
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... The ... OSHA Training Institute Education Center headquartered in Northern California, has issued an important ... heat at their worksites. Employers with workers exposed to high temperatures should ...
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media ... Pro X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice ... X users can now reveal the media of their split screens with growing ...
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, ... today its affiliation with Tennessee Counseling Association. This new relationship allows ... the Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA is ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... industry today announced its strategic partnership with Connance, a healthcare industry leader ... two companies’ proven, proprietary technology combine to provide health systems, hospitals and ...
(Date:6/27/2016)... Brooklyn, NY (PRWEB) , ... June 27, 2016 ... ... is using cutting edge technology to revolutionize the emergency ambulance transport experience for ... Many are aware of how Uber has disrupted the taxi industry through the ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... June 26, 2016 One of Australia,s ... the formation of a new biotechnology company, Noxopharm Limited [ABN 50 ... an IPO and to list on the ASX. Noxopharm ... ready to enter a Phase 1 clinical study later this year. ... address one of the biggest problems facing cancer patients - the ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) announced ... Act of 1976, as amended ("HSR"), with respect to ... CPXX ) expired effective June 24, 2016, ... previously announced on May 31, 2016, Jazz Pharmaceuticals and ... Jazz Pharmaceuticals has commenced a tender offer for all ...
(Date:6/26/2016)... 27, 2016  VMS Rehab Systems, Inc. ( ... whatever measures required to build a strong and stable ... currently listed on the OTC Markets-pink current trading platform. ... CEO, "We are seeing an anomaly in market trading ... only by the Company, but shareholders and market players ...
Breaking Medicine Technology: